DHR
58
-5
FLS
52
-3
PCAR
36
-3
ECL
59
2
V
40
2
UA
26
2
MMC
53
5
MCK
52
2
AMGN
33
2
AZO
58
5
NEE
67
13
CRM
49
4
SIG
46
5
NTAP
46
-9
GE
78
6
SYY
52
3
HRL
32
-4
ALL
44
3
FTI
68
-10
YUM
59
-3
DHR
58
-5
FLS
52
-3
PCAR
36
-3
ECL
59
2
V
40
2
UA
26
2
MMC
53
5
MCK
52
2
AMGN
33
2
AZO
58
5
NEE
67
13
CRM
49
4
SIG
46
5
NTAP
46
-9
GE
78
6
SYY
52
3
HRL
32
-4
ALL
44
3
FTI
68
-10
YUM
59
-3
Financhill
Back

TransMedics Group Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50

TMDX
TransMedics Group

Last Price:
$115.65
Seasonality Move:
-15.87%

7 Day Trial

ALL ACCESS PASS

$ 7

TransMedics Group Stock Forecast

  • Over the next 52 weeks, TransMedics Group has on average historically risen by 46% based on the past 6 years of stock performance.
  • TransMedics Group has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is TransMedics Group Stock Undervalued?
    The current TransMedics Group [TMDX] share price is $116.88. The Score for TMDX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • TMDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will TransMedics Group Stock Go Up Next Year?

  • Over the next 52 weeks, TransMedics Group has on average historically risen by 46% based on the past 6 years of stock performance.

TransMedics Group Stock Rating

Sell
50
TransMedics Group (TMDX) is a Sell

Is TransMedics Group overpriced?

  • TransMedics Group has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

TransMedics Group Stock Price History

Is TMDX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TMDX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
transmedics.com

52-Week Data

52-Week High:
177.37
52-Week Low:
55.00

Prediction Charts

Market Cap:
4B
Price in USD:
116.88
Volume:
1.3M
Beta:
2.01

Technical Analysis

SMA50:
123.89
SMA100:
99.64
SMA200:
94.97
52-Wk Change:
-17.8%

Stock Predictions

  • Is TransMedics Group stock public?
    Yes, TransMedics Group is a publicly traded company.
  • What is the TransMedics Group stock quote today?
    The TransMedics Group stock price is 116.88 USD today.
  • How to buy TransMedics Group stock online?
    You can buy TransMedics Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-24 128.59 132.64 133.49 126.29
Jun-25 133.35 128.58 133.35 128.00
Jun-26 129.00 130.06 131.35 128.13
Jun-27 130.79 131.45 133.02 129.66
Jun-30 132.10 134.01 135.82 132.10
Jul-1 133.80 130.10 136.63 128.61
Jul-2 129.92 127.69 130.70 125.10
Jul-3 127.37 129.19 129.19 124.50
Jul-7 127.84 125.17 128.01 123.25
Jul-8 125.16 124.73 128.06 124.23
Jul-9 125.00 126.41 126.54 122.48
Jul-10 125.97 124.78 127.97 123.80
Jul-11 122.70 112.46 123.50 109.59
Jul-14 112.18 116.88 119.46 111.93

TransMedics Group Earnings

TransMedics Group Earnings Report: Per Share TransMedics Group Earnings Q1 Q2 Q3 and Q4 last year and next year.

TransMedics Group Forecast Revenue Growth

TransMedics Group Stock Analysis: Historical quarterly revenues per share for TransMedics Group and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.34 per share, an increase this year of $0.83 per share, and an increase next year of $0.68 per share.

* TransMedics Group stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.